MCV2 is a vaccine used for the prevention of N. meningitides
(Lta). Our MCV2 candidate is a potential best-in-class MCV2
vaccine in China. Compared with current primary MCV2
products approved in the PRC, our MCV2 candidate has
demonstrated a better safety profile and better immunogenicity
in its phase III clinical trial.
Copyright © ( 2017) CanSino Biologics Inc
For the record: 津ICP备14006666号-2